DACILON DACTINOMYCIN INJECTION

Get a Price/Quote

DACILON DACTINOMYCIN INJECTION Specification

Indication
Indicated for various cancers including Wilms tumor, childhood rhabdomyosarcoma, Ewings sarcoma, and gestational trophoblastic neoplasia

Origin of Medicine
Allopathic

Dosage Form
Lyophilized Powder for Injection

Salt Composition
Dactinomycin 0.5mg

Pacakaging (Quantity Per Box)
1 vial per box

Drug Type
Prescription only, cytotoxic agent

Ingredients
Dactinomycin (also known as Actinomycin D)

Physical Form
Injection

Function
Antineoplastic (anti-cancer agent)

Recommended For
Cancer treatment (Wilms tumor, rhabdomyosarcoma, Ewings sarcoma, gestational trophoblastic neoplasia, and others as directed by a physician)

Dosage
As directed by healthcare professional, individualized per patient and indication

Dosage Guidelines
Administered intravenously under medical supervision

Suitable For
Adults and children as prescribed

Quantity
Each vial contains Actinomycin D 0.5 mg

Storage Instructions
Store below 25C, protect from light, do not freeze

Registration Status
Registered pharmaceutical product

Side Effects
May include myelosuppression, nausea, vomiting, oral mucositis, diarrhea, and hepatic toxicity

Warnings and Precautions
Use with caution in hepatic or renal impairment; Myelosuppression risk; Only for use under specialist supervision

Reconstitution
Reconstitute in sterile water for injection before use

Appearance
Lyophilized yellow powder in a glass vial

Brand Name
Dacilon

Shelf Life
See product package for expiry date

Contraindications
Contraindicated in patients with hypersensitivity to dactinomycin or any inactive ingredients

Route of Administration
Intravenous

DACILON DACTINOMYCIN INJECTION Trade Information

Packaging Details
PACK OF 1VIAL

Main Domestic Market
All India

About DACILON DACTINOMYCIN INJECTION

Specifications:-

Brand Name : DACILON
Content : Dactinomycin
Strength: 0.5 Mg
Form :Injection
Packing :Pack of 1Vial
Manufactured By : Celon Lab

Note : - DACILON Is A Prescription Drug And Should Be Used Under Proper Medical Guidance And Advice. Do Not Share The Medicine With Others, Since They May Be Suffering From A Problem That Is Not Effectively Treated By This Drug............

Specialist-Supervised Cancer Therapy

DACILON DACTINOMYCIN INJECTION is designed specifically for use under specialized medical supervision due to its potent cytotoxic effects and associated risks. The therapy is tailored to each patients specific cancer type, factoring in their medical history, and organ function, ensuring the optimal balance between efficacy and safety.

Flexible Intravenous Administration

Dacilon is supplied as a lyophilized powder that must be reconstituted with sterile water before intravenous use. This mode of administration enables precise dosing, making it suitable for both adults and children as directed by an oncologist or specialist. Intravenous delivery ensures the drug is rapidly available to act against cancer cells.

Comprehensive Cancer Indications

Dacilon is indicated for various malignancies, including Wilms tumor, Ewings sarcoma, childhood rhabdomyosarcoma, and gestational trophoblastic neoplasia. By inhibiting cancer cell replication, it forms an integral part of multi-agent treatment protocols, improving the chances of disease control and long-term patient outcomes.

FAQs of DACILON DACTINOMYCIN INJECTION:

Q: How should Dacilon (Dactinomycin Injection) be administered?

A: Dacilon must be administered intravenously after proper reconstitution with sterile water for injection. The procedure should be performed exclusively by trained healthcare professionals in a clinical setting.

Q: What are the main uses of Dacilon?

A: Dacilon is primarily indicated for the treatment of several cancers, such as Wilms tumor, childhood rhabdomyosarcoma, Ewings sarcoma, and gestational trophoblastic neoplasia, as part of combination chemotherapy regimens.

Q: When should I not use Dacilon?

A: Dacilon is contraindicated in individuals with known hypersensitivity to dactinomycin or any of its components. It should be avoided in patients who have previously exhibited allergic reactions to this medication.

Q: Where should reconstituted Dacilon be stored, and how is it prepared?

A: The vial should be stored below 25C, protected from light; do not freeze. Before use, reconstitute the yellow powder with sterile water for injection, following aseptic techniques as detailed by medical guidelines or the product insert.

Q: What precautions should be taken during Dacilon therapy?

A: Extreme caution is required in patients with hepatic or renal impairment due to increased risk of toxicity, and regular monitoring for myelosuppression is necessary. The drug should be used only under the supervision of a specialist experienced in cancer chemotherapy.

Q: What side effects might occur with Dacilon therapy?

A: Possible side effects include myelosuppression (decreased blood cell counts), nausea, vomiting, oral mucositis, diarrhea, and liver toxicity. It is essential to report any unusual symptoms to the healthcare provider promptly.

Q: What benefit does Dacilon offer in cancer treatment?

A: Dacilon disrupts cancer cell DNA synthesis, helping to control and reduce tumor growth. Its inclusion in multi-drug cancer protocols supports improved remission rates in a variety of pediatric and adult malignancies under specialized care.

Tell us about your requirement